LOADING
Comparing Merck & Company (MRK) and Pfizer Inc (PFE), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $294.4B | $156.8B |
| P/E Ratio | 16.4 | 20.3 |
| Forward P/E | 23.3 | 9.4 |
| PEG Ratio | 3.64 | 13.77 |
| EPS | $7.28 | $1.36 |
| Revenue Growth (YoY) | 5.0% | -1.2% |
| Profit Margin | 28.1% | 12.4% |
| Return on Equity | 36.9% | 8.9% |
| Dividend Yield | 2.81% | 6.32% |
| Beta | 0.28 | 0.39 |
| 52-Week High | $124.22 | $28.75 |
| 52-Week Low | $70.74 | $20.39 |
| Volume | -- | -- |
Merck & Company is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.